The four-day event marks the first time since 2019 that industry leaders will meet face-to-face to address global challenges - from the pandemic to DE&I
WASHINGTON, May 24, 2022--(BUSINESS WIRE)--DIA, the premier professional global community for healthcare product development, will host its in-person Global Annual Meeting in Chicago on June 19-23. This event marks the first time since 2019 that the association has convened global industry, regulators, academics, and patients together face-to-face with a goal of exploring and discussing some of the life science industry’s most pressing challenges and opportunities.
Attendees will benefit from DIA’s neutral, transparent platform, which provides an opportunity for top leaders and minds in the clinical trial and drug development fields to co-create, problem-solve and discuss global and regional challenges faced by all stakeholders in the life sciences community.
DIA’s Global Annual Meeting 2022 includes over 150 sessions across 13 educational tracks, covering topics such as FDA regulations with insights from FDA officials, navigating global crises, patient-focused drug development, DE&I, real-world data collection and utilization, and more. These sessions, led by global and regional experts from some of the top life science organizations and associations, will inspire a worldwide discussion, representing many multidisciplinary perspectives to achieve actionable, innovative solutions between pharma, regulatory agencies, patients, academia and beyond.
"In the last several years, the life science industry has been front-and-center facing global crises - from the unprecedented COVID-19 pandemic to the crisis in Ukraine. Organizations across the globe have had to adapt, quickly, and as a result our industry will never be the same," said Barbara Lopez Kunz, President and Global Chief Executive of DIA. "This year’s Global Annual Meeting is an opportunity for clinical development leaders, experts, researchers and patients to finally reunite for open and honest collaboration that will impact our toughest challenges - both locally and globally."
Highly anticipated sessions at the event include:
The Future of Healthcare: Opening plenary session will feature the multi-perspective importance of accessibility to inclusive and patient-centric treatments, and forward-looking discussion on the future of healthcare.
FDA Town Hall: Offers direct exchange and dialogue with FDA leaders to inspire innovative solutions to 2022’s life sciences challenges.
Asia and China Town Halls: Explore the future of clinical trials and drug development in these regions, as well as the latest efforts for regulatory convergence.
Attendees and interested parties can learn more about popular topics that will be covered at DIA’s Global Annual Meeting by exploring the searchable event program, and by registering for the event here.
DIA (founded as the Drug Information Association) is a global association that mobilizes life science professionals from across all areas of expertise to engage with patients, peers, and thought leaders in a neutral environment on the issues of today and the possibilities for tomorrow. As a member-driven, volunteer organization, professionals from 80 countries have affected healthcare outcomes by engaging with DIA through an unparalleled network, educational offerings, and professional development opportunities.
DIA is based in Washington, DC (US) with regional offices representing the Americas (Horsham, PA, US); Europe, the Middle East, and Africa, (Basel, Switzerland); and Asia (Beijing and Shanghai, China; Mumbai, India; and Tokyo, Japan).
Learn more and register for the DIA Global Annual Meeting 2022 at DIAglobal.org/DIA2022. For live updates, search social media with #DIA2022, and connect with DIA on Twitter, LinkedIn, Facebook, and Instagram.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220524005770/en/
Emily Daniele, Associate Marketing Director, Americas
+1 (215) 442-6106